Core Laboratories (CLB) Tops Q1 EPS by 1c, Offers Q2 Guidance

Core Laboratories (NYSE: CLB) reported Q1 EPS of $0.44, $0.01 better than the analyst estimate of $0.43. Revenue for the quarter came in at $169.2 million versus the consensus estimate of $166.63 million.

GUIDANCE:

Core Laboratories sees Q2 2019 EPS of $0.47-$0.50, versus the consensus of $0.49. Core Laboratories sees Q2 2019 revenue of $172-175 million, versus the consensus of $174.3 million.

For earnings history and earnings-related data on Core Laboratories (CLB) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• KeyBanc Downgrades Kite Realty Group (KRG) to Sector Weight
• INVO Fertility (IVF) Tops Q2 EPS by 105c